DNA sequencing future developments Flashcards
5 phases of sequencing
- maxam-gilbert chemical cleavage DNA Seq: slow
- Sanger sequencing w/ ddNTPs = terminate rxn
- Pyrosequencing
- Next generation sequencing: multiple rxn per bead
- Next-next gen sequencing: detect DNA as move through nanopore
disadvantage to pyrosequencing
rxn vol inc = efficiency dec
*from adding nucleotides for each rxn cycle
what techniques are combined in Next gen sequencing
- (cloning) Amplification (454 method)
- (direct molecule) Sequencing (Helicos, pacific biosystem method)
- Automation
describe technique of next gen sequencing
- all use polymerase or ligase
- detect sequence using fluorescence or chemiluminescence
Describe the general amplification technique in next gen
- water in oil emulsion PCR (emPCR) => 1 bead + 1 DNA fragment w/ linker (known sequ) per vesicle
- OR surface PCR (solexa)
Describe the 454 amplification method
- emulsion PCR
- DNA amplify on bead
- each bead go into separate wells
- pack wells w/ sequencing reagents: enzymes
- pyrosequencing rxn
Describe the sequencing helicos method
- no amplification
- dNTP labeled w/ dye
- cycles of 1 dNTP per rxn -> image -> chemically cleave dye for next rxn cycle ->repeat
Describe the sequencing pacific biosciences method
- amplified DNA goes through pol. => sequenced
- when base added = fluores
- Hairpin loop inc accuracy
Describe the sequencing illumina method
- primers on slide = amplification
- labeled reversible terminator dNTP = detected by laser
Describe the sequencing ion torrent method
- detect pH change when dNTP is incorporated bc H+ released
Describe next-next gen sequencing
- DNA moves through nanopore => detected by “solid state”
- measure change in impedance (disruption in current)
Research applications (5-7)
- genome resequencing
- targeted genome resequencing
- cancer genomics
- pharmacogenomics
- transcriptome
- methylation analysis
- micro RNA profiling
types of variations detected by next gen sequencing
- point mutation
- deletions & insertions
- translocation breakpoint
- pathogen
challenges of clinical applications (Of next gen sequ)
- methological challenges
- changing from monogenic to polygenic disease
- uncertainty of some results
- predicted freq. of recessive mutations in pop